iRadimed Corp IRMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $97.77
- Day Range
- $96.25–97.94
- 52-Week Range
- $55.11–107.90
- Bid/Ask
- $96.93 / $97.21
- Shares Outstanding
- 12.78M
- Market Cap
- $1.24B
- Volume/Avg
- 61,746 / 135,469
Key Statistics
- Price/Earnings (Normalized)
- 49.86
- Price/Sales
- 14.58
- Dividend Yield (Trailing)
- 0.76%
- Dividend Yield (Forward)
- 0.82%
- Total Yield
- 0.76%
Company Profile
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 166
- Website
- https://www.iradimed.com
Valuation
|
Metric
|
IRMD
|
|---|---|
Price/Earnings (Normalized) | 49.86 |
Price/Book Value | 12.69 |
Price/Sales | 14.58 |
Price/Cash Flow | 41.40 |
Price/Earnings
IRMD
Financial Strength
|
Metric
|
IRMD
|
|---|---|
Quick Ratio | 5.76 |
Current Ratio | 7.13 |
Interest Coverage | — |
Quick Ratio
IRMD
Profitability
|
Metric
|
IRMD
|
|---|---|
Return on Assets (Normalized) | 23.63% |
Return on Equity (Normalized) | 27.12% |
Return on Invested Capital (Normalized) | 27.12% |
Return on Assets
IRMD
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|t<wbtqd | LOCK|#^cN | $155B | |||
| Stryker Corp
SYK
| LOCK|f#ny<xG | LOCK|&$ | $121B | |||
| Medtronic PLC
MDT
| LOCK|n<W$$<C | LOCK|H^Bbv | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|#@%G&> | LOCK|#m%? | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%jZ#?kPV | LOCK|V$JQ | $50B | |||
| DexCom Inc
DXCM
| LOCK|^q<RPp< | LOCK|<>NJh | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|?h&^%Ms | LOCK|^! | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|<M | LOCK|!& | $26B | |||
| Steris PLC
STE
| LOCK|%g?M%P< | LOCK|mz!<M | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|#X!%Z!s | LOCK|%X? | $17B |
United States